. Author manuscript; available in PMC: 2017 Nov 9.

Published in final edited form as: Sci Transl Med. 2017 Feb 15;9(377):eaag1809. doi: 10.1126/scitranslmed.aag1809

Table 1. Clinical characteristic of study participants.

	HIV^- (n=14)	AHI 4G Stage1 (n=22)	AHI 4G Stage2 (n=37)	AHI 4G Stage3 (n=47)

AHI 4^th Generation Staging		NAT+ 4^th G-/3^rd G-	NAT+ 4^th G+/3^rd G-	NAT+ 4^th G+/3^rd G+ WB- or IND

Days since HIV Exposure, Median (IQR)	NA	14 (9-19)	16 (13-20)	19 (13-23)
Age (yrs), mean (SD)	32.7 (6.9)	28.8 (8.3)	28.4 (7.3)	27.8 (6.7)
Male/ Female ratio	8/6	20/2	36/1	45/2
CD4 count cells/μl in plasma, Median (IQR)	NA	526.5 (334.3-575.5)	304 (237.5-457)	386 (295-506)
CD8 count cells/μl in plasma, Median (IQR)	NA	399.5 (262-482.3)	240 (196-391)	638 (425-1058)